Trial intelligence / Profile preview

E. coli Nissle 1917 for Chemotherapy-Induced Diarrhea

NCT02706184Phase 3Completed

Sponsor
Universität Hohenheim
Start
Jul 2015
Primary completion
Jan 2018
Modality
Live Biotherapeutic Products
Countries
1
01

Overview

A Phase 3 trial of escherichia coli nissle 1917 in diarrhea, sponsored by Universität Hohenheim. Started Jul 2015; status: completed.

02

Drugs

escherichia coli nissle 1917
03

Conditions

diarrhea

Beyond the preview

Go deeper on NCT02706184.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02706184.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call